Home » Topics » Regulatory » Patents

Patents
RSS

Isoflavone derivatives for osteoporosis with advantages over previously reported compounds

Oct. 20, 1998

New AMPA and NMDA receptor antagonists in early research at RPR

Oct. 20, 1998

Paclitaxel derivatives useful as antitumor agents prepared at BMS

Oct. 20, 1998

Neurotrophic/neuroprotective agents in development at Sanofi

Oct. 20, 1998

Nitromethylthiobenzene derivatives as aldose reductase inhibitors

Oct. 19, 1998

Subtype-selective 5-HT1D agonists developed at MS&D for migraine

Oct. 19, 1998

Bristol-Myers Squibb discloses novel MTP inhibitors

Oct. 19, 1998

Orally active thrombin inhibitors prepared at ADIR as anticoagulants

Oct. 19, 1998

Lundbeck describes novel class for psychiatric and neurological disorders

Oct. 19, 1998

Scientists at Cell Therapeutics disclose new signal transduction inhibitors

Oct. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.